ACUTAAS Q2 FY27 Guidance vs Delivery (ACUTAAS Management Mirror)

Did ACUTAAS's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q2 FY27 (Sep-2026 Qtr) concall.

Acutaas Chemicals Ltd (ACUTAAS) Q2FY27 Management Mirror - Sep-2026 Qtr

FY27 EBITDA Margin Guidance Upgraded to 38%-40% in Sep'26 Qtr From 34.5%-36% Guided in Mar'26 Qtr

H1 FY27 EBITDA margin reached 37.7% and Q2 FY27 expanded to 40.3%, as reported in Sep'26 Qtr results. In the Mar'26 and Jun'26 Qtr concalls, management had initially guided for full-year FY27 EBITDA margins to remain stable at FY26 levels of around 34.5% to 36%. Tracking ahead of this expectation, management upgraded its FY27 EBITDA margin guidance to a range of 38% to 40% in the Sep'26 Qtr concall. This upgraded outlook is supported by a higher product mix contribution from the high-margin CDMO segment and operating leverage as production scales across facilities.

4 more themes on the ELITE plan.